THE PROGRAM

08:00

Registration and Morning Refreshments

09:00

Welcome Address

09:15

Keynote Lecture: Prof. Matthew Porteus, Stanford Medical School, USA

Genome Editing for the Hematopoietic System: Continuing Advances

10:00

Prof. Eithan Galun – HUJI

MicroRNAs: from target identification to therapeutic approaches

10:20

Dr. Shlomit Kfir-Erenfeld - HUJI

Driving CARs to Israel: Local development of BCMA CAR T cells for the treatment of multiple myeloma​

10:40

Dr. Ayal Hendel – BIU

CRISPR-Cas9 RAG2-SCID Correction via Coding Sequence Replacement to Preserve Endogenous Gene Regulation and Locus Structure

11:00

Coffee Break

11:30

Prof. Cyrille Cohen - BIU

Enhanced T-cells for immunotherapy with novel switch receptors and redirected metabolism​

11:50

Dr. Elad Jacoby – Sheba Medical Center

Mitochondrial Augmentation of Hematopoietic Stem Cells -  First-in-human Experience

12:10

Prof. Roi Gazit - BGU

CARTIV- Chimeric Antigen Receptor within Tumor Induced Vector

12:30

Dr. Tawfeeq Shekh-Ahmad - HUJI

A New Approach for Treating Epilepsy: CNS-Targeted Antioxidant Gene Therapy

12:38

Ms. Saja Fadila - TAU

Adenovirus-mediated expression of NaV1.1 ameliorates Dravet syndrome epilepsy in mice 

Dr. Dikla Berko - Sakura Bio

Developing an Off-the-shelf, Allogeneic and Highly Effective Cell Therapy against Leukemia

Dr. Tomer Itkin - TAU

Transcriptional Activation of Regenerative Hematopoiesis via Co-Adaptability with a Vascular Niche

Ms. Sapir Shcoory - WIS

Novel bacteria-based biological delivery system for selective TACE (ADAM17) inhibition

13:10

Dr. Rona Harari Steinfeld - Arsenal Biosciences

AB-1015, an Integrated Circuit T Cell Therapy Targeting Ovarian Cancer, Incorporating an ALPG/MSLN Logic Gate and FAS/PTPN2 shRNA-miR

13:18

Lunch and Poster Session

15:00

Dr. Yona Geffen - Gamida-Cell

From scientific idea to FDA approved Drug, challenges in cell therapy drug development

15:20

Dr. Liat Rockah - Emendo Bio

Newly Discovered Engineered CRISPR-Associated Nucleases as a Robust, Efficient, Allele- and Target-Specific Editing Tool

15:40

Prof. Aviva Fattal-Valevski - TASMC/TAU

Gene Therapy in Real Life​

16:00

Dr. Marianna Truman - Pluri

Placenta-based allogeneic platform for regenerative medicine​

16:20

Prof. Rachela Popovtzer - BIU

The Beauty of gold: endless configurations for drug delivery, imaging, tracking and patient stratification

16:40

Closing Remarks